Product Recalls in Pennsylvania

Product recalls affecting Pennsylvania — including food, drugs, consumer products, medical devices, and vehicles distributed to Pennsylvania. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,919 recalls have been distributed to Pennsylvania in the last 12 months.

55,602 total recalls
2,919 in last 12 months

Showing 861880 of 13,473 recalls

DrugNovember 6, 2024· Tailstorm Health INC

Recalled Item: BEVACIZUMAB (AVASTIN)1.25mg/0.05mL Recalled by Tailstorm Health INC Due to...

The Issue: Lack of Sterility Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 6, 2024· Trinity Gold Nutrition

Recalled Item: Trinity Gold Nutrition Recalled by Trinity Gold Nutrition Due to Undeclared...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 5, 2024· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Hydralazine HCl Tablets Recalled by The Harvard Drug Group LLC dba Major...

The Issue: Failed Impurities/Degradation Specifications; during routine stability...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 4, 2024· Boulla LLC

Recalled Item: ZapMax Capsules Recalled by Boulla LLC Due to Undeclared Sildenafil

The Issue: Marketed without an approved NDA/ANDA: Products found to contain undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 4, 2024· Boulla LLC

Recalled Item: VitalityXtra Capsules Recalled by Boulla LLC Due to Undeclared Sildenafil

The Issue: Marketed without an approved NDA/ANDA: Products found to contain undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 4, 2024· Boulla LLC

Recalled Item: PeakMax Capsules Recalled by Boulla LLC Due to Undeclared Sildenafil

The Issue: Marketed without an approved NDA/ANDA: Products found to contain undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 4, 2024· Boulla LLC

Recalled Item: ZoomMax Capsules Recalled by Boulla LLC Due to Undeclared Sildenafil

The Issue: Marketed without an approved NDA/ANDA: Products found to contain undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules Recalled by Glenmark...

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules Recalled by Glenmark...

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules Recalled by Glenmark...

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules Recalled by Glenmark...

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules Recalled by Glenmark...

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules Recalled by Glenmark...

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 1, 2024· JR Watkins

Recalled Item: Cooling Menthol Extra Strength Pain Relief Patch Recalled by JR Watkins Due...

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 31, 2024· Noven Pharmaceuticals Inc

Recalled Item: Xelstrym (dextroamphetamine) transdermal system Recalled by Noven...

The Issue: Defective Delivery System: The product does not meet predetermined...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 30, 2024· Baxter Healthcare Corporation

Recalled Item: Regadenoson Injection Recalled by Baxter Healthcare Corporation Due to...

The Issue: Labeling: Missing Label

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: IBU (ibuprofen) 600 mg tablets Recalled by Dr. Reddy's Laboratories, Inc....

The Issue: Failed Tablet/Capsule Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 29, 2024· VIONA PHARMACEUTICALS INC

Recalled Item: Dapsone Gel 7.5% Recalled by VIONA PHARMACEUTICALS INC Due to Crystallization

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 25, 2024· Lannett Company Inc.

Recalled Item: Lisdexamfetamine Dimesylate Capsules Recalled by Lannett Company Inc. Due to...

The Issue: Failed Content Uniformity Specifications: Product failed to meet the action...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: THERACARE Cold Hot Medicated Patch Recalled by Unexo Life Sciences Private...

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund